Life Science

Global Molecular Imaging Agents Market Report: Regional Data Analysis by Production, Revenue, Price and Gross Margin

Molecular imaging is a new biomedical research discipline which enables the quantification, visualization, and characterization of biologic processes taking place at the cellular and subcellular levels. Molecular imaging plays a very important role in diagnosis of early assessment, risk stratification, and follow-up of patients with neurological diseases. Imaging agents are the substances designed to improve the imaging output of specific organs, physiological functions, tissues and diseases. Molecular imaging agents are small molecules, peptides, engineered proteins, aptamers and nanoparticles. The main purpose of a molecular imaging agent is to cross-examine and report back about a specific target of interest during the course of a molecular imaging study.

Based on types, the global molecular imaging agents market is segmented into small molecules, peptides, engineered protein fragments, aptamers, nanoparticles and others. Amongst all, peptides have emerged as a very important type of molecular imaging agents. Based on application, the global molecular imaging agents market is segmented into oncology, cardiology, gastrointestinal disorders and neurology disoeder. Similarly, based on end user, the market is segmented into, hospitals and clinics, ambulatory surgical centers, diagnostic & imaging centers, and others. Diagnostic & imaging centers are expected to hold maximum share in the market due to the ease of availability of medication.

North America is the leading region of molecular imaging agents market owing to increasing awareness for molecular imaging in disease diagnosis and monitoring. Europe and Asia region are also growing at rapid pace for molecular imaging agents owing to increase in research and development (clinical trials) activities across biopharmaceutical drugs.

Access Report Details at: https://www.themarketreports.com/report/global-molecular-imaging-agents-market-research-report

The global Molecular Imaging Agents market is valued at xx million US$ in 2018 is expected to reach xx million US$ by the end of 2025, growing at a CAGR of xx% during 2019-2025.

This report focuses on Molecular Imaging Agents volume and value at global level, regional level and company level. From a global perspective, this report represents overall Molecular Imaging Agents market size by analyzing historical data and future prospect. Regionally, this report focuses on several key regions: North America, Europe, China and Japan.

Key companies profiled in Molecular Imaging Agents Market report are General Electric, Bracco Diagnostic, Eisai, Guerbet and more in term of company basic information, Product Introduction, Application, Specification, Production, Revenue, Price and Gross Margin (2014-2019), etc.

Purchase this Premium Report at: https://www.themarketreports.com/report/buy-now/1432779

Table of Content

1 Molecular Imaging Agents Market Overview

2 Global Molecular Imaging Agents Market Competition by Manufacturers

3 Global Molecular Imaging Agents Production Market Share by Regions

4 Global Molecular Imaging Agents Consumption by Regions

5 Global Molecular Imaging Agents Production, Revenue, Price Trend by Type

6 Global Molecular Imaging Agents Market Analysis by Applications

7 Company Profiles and Key Figures in Molecular Imaging Agents Business

8 Molecular Imaging Agents Manufacturing Cost Analysis

9 Marketing Channel, Distributors and Customers

10 Market Dynamics

11 Global Molecular Imaging Agents Market Forecast

12 Research Findings and Conclusion

13 Methodology and Data Source